6.13
Poiché molti recettori leganti sono idrofili, non attraversano la membrana cellulare e quindi il loro messaggio deve essere trasmesso a un secondo mes…
[Narratore] Quando i messaggi vengono ricevuti
sulla superficie delle cellule
i messaggeri secondari trasmettono questi messaggi
per indirizzare le molecole all'interno della cellula
e creare una risposta.
Un'importante cascata di segnali intracellulari
è l'inositolo trifosfato diacilglicerolo
o via IP3 / DAG.
Sulla superficie cellulare, ormoni e neurotrasmettitori
legarsi ai recettori accoppiati a proteine G che attivano
un enzima, come la come fosfolipasi C.
Questo enzima si idrolizza o si rompe con l'acqua,
lo strato interno dello strato di fosfolipidi,
ottenendo due secondi messenger, DAG e IP3.
Il DAG rimane nella membrana plasmatica e recluta proteine
Chinasi C mentre IP3 si diffonde attraverso il citoplasma
e si lega ai recettori IP3 sul reticolo endoplasmatico
causando la liberazione di ioni calcio nel citoplasma.
Questi ioni di calcio si legano e si attivano
la proteina chinasi C, che fosforolata
altre proteine intracellulari
risultante in una risposta cellulare.
View the full transcript and gain access to JoVE Core videos
Q1: Why do cells need second messengers to relay signals?
Hydrophilic ligands like hormones and neurotransmitters cannot cross the cell membrane, so their messages must be relayed by second messengers inside the cell. Second messengers amplify and transmit signals from cell surface receptors to intracellular targets, enabling a cellular response. This system allows cells to respond to external signals without the ligand entering the cytoplasm.
Q2: How does the IP3/DAG pathway generate second messengers?
When hormones or neurotransmitters bind to G-protein coupled receptors, they activate phospholipase C. This enzyme hydrolyzes phosphatidylinositol biphosphate (PIP2) in the plasma membrane, producing two second messengers: diacylglycerol (DAG) and inositol triphosphate (IP3). This single enzymatic reaction generates both signaling molecules simultaneously.
Q3: What happens after DAG and IP3 are released in the cell?
DAG remains in the plasma membrane where it recruits and activates protein kinase C (PKC). IP3 diffuses through the cytoplasm and binds to IP3 receptors on the endoplasmic reticulum, triggering calcium ion release. These calcium ions then activate PKC, which phosphorylates other intracellular proteins to produce the cellular response.
Q4: What are the main types of second messenger pathways?
G-protein coupled receptors activate phosphoinositol and cyclic AMP (cAMP) pathways. The phosphoinositol pathway produces DAG and IP3, while the cAMP pathway generates multiple cAMP copies from ATP molecules. Additionally, cyclic GMP (cGMP) is synthesized from GTP when guanylyl cyclase is activated, and PIP3 is generated when growth factors bind receptor tyrosine kinases.
Q5: How does cAMP function as a second messenger?
When adenylate cyclase is activated by G-protein coupled receptors, it produces multiple copies of cAMP from ATP molecules. cAMP can stimulate protein kinase A (PKA), open calcium ion channels, and activate Exchange-protein activated by cAMP (Epac). This amplification allows a single receptor activation to generate numerous cAMP molecules, intensifying the signal.
Q6: What is the role of cGMP in cell signaling?
cGMP is synthesized from guanosine triphosphate (GTP) when guanylyl cyclase is activated. As a second messenger, cGMP induces protein kinase G (PKG), which has overlapping functions with protein kinase A. However, PKG expression is restricted to vascular tissues, lungs, and the brain, limiting cGMP signaling to specific cell types.
Q7: How does PIP3 regulate cell survival pathways?
PIP3 is generated when growth factors bind receptor tyrosine kinases, triggering phosphorylation of PIP2. PIP3 recruits Akt (protein kinase B) to the membrane, where it regulates critical cell survival pathways including proliferation, apoptosis, and migration. This positioning allows Akt to control whether cells survive, divide, or undergo programmed death.